Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.verified

HYL.BR

Price:

$5.94

Market Cap:

$166.32M

Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. It also provides other products, such as post operation pain, dental indications, severe and recurring vulvovaginal candidiasis, acute myeloid leukemia and small cell lung cancer, IC/PBS, attention deficit hyperactivity disorder, and viral infection. Hyloris Pharmaceuticals SA was inco...[Read more]

Industry

Biotechnology

IPO Date

2020-06-29

Stock Exchange

BRU

Ticker

HYL.BR

The Enterprise Value as of December 2025 (TTM) for Hyloris Pharmaceuticals S.A. (HYL.BR) is 149.36M

According to Hyloris Pharmaceuticals S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 149.36M. This represents a change of -4.60% compared to the average of 156.55M of the last 4 quarters.

Hyloris Pharmaceuticals S.A. (HYL.BR) Historical Enterprise Value (quarterly & annually)

How has HYL.BR Enterprise Value performed in the past?

The mean historical Enterprise Value of Hyloris Pharmaceuticals S.A. over the last ten years is 215.32M. The current 149.36M Enterprise Value has changed 6.84% with respect to the historical average. Over the past ten years (40 quarters), HYL.BR's Enterprise Value was at its highest in in the December 2021 quarter at 409.18M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

215.32M

Median

251.23M

Minimum

2.27M

Maximum

409.18M

Hyloris Pharmaceuticals S.A. (HYL.BR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hyloris Pharmaceuticals S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 10.98%

Maximum Annual Enterprise Value = 409.18M

Minimum Annual Increase = -74.17%

Minimum Annual Enterprise Value = 2.27M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024168.15M-48.79%
2023328.35M20.30%
2022272.94M-33.30%
2021409.18M115.98%
2020189.46M191.74%
201964.94M-74.17%
2018251.38M0.06%
2017251.23M10.98%

Hyloris Pharmaceuticals S.A. (HYL.BR) Average Enterprise Value

How has HYL.BR Enterprise Value performed in the past?

The current Enterprise Value of Hyloris Pharmaceuticals S.A. (HYL.BR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

256.48M

5-year avg

273.62M

10-year avg

215.32M

Hyloris Pharmaceuticals S.A. (HYL.BR) Enterprise Value vs. Peers

How is HYL.BR’s Enterprise Value compared to its peers?

Hyloris Pharmaceuticals S.A.’s Enterprise Value is less than Onward Medical N.V. (156.69M), greater than Celyad Oncology S.A. (8.21M), greater than European Medical Solutions (38.51M), greater than BioSenic S.A. (21.84M), greater than Oxurion N.V. (11.32M), greater than Sequana Medical N.V. (86.63M), less than Ion Beam Applications S.A. (390.87M),

Build a custom stock screener for Hyloris Pharmaceuticals S.A. (HYL.BR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hyloris Pharmaceuticals S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hyloris Pharmaceuticals S.A. (HYL.BR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hyloris Pharmaceuticals S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Hyloris Pharmaceuticals S.A.'s Enterprise Value?

What is the highest Enterprise Value for Hyloris Pharmaceuticals S.A. (HYL.BR)?

What is the 3-year average Enterprise Value for Hyloris Pharmaceuticals S.A. (HYL.BR)?

What is the 5-year average Enterprise Value for Hyloris Pharmaceuticals S.A. (HYL.BR)?

How does the current Enterprise Value for Hyloris Pharmaceuticals S.A. (HYL.BR) compare to its historical average?